Sponsor League Table
59 sponsors ranked · ≥3 corpus deals · sorted by median_moic
🛡️ Public data only — no PHI permitted on this instance.
Sponsors Ranked
59
≥3 deals in corpus
Best P50 MOIC
4.65×
Shore Capital
Zero-Loss Sponsors
44
no impairments in corpus
Avg Consistency
75
score out of 100
Corpus Deals
655
total across all sponsors
SPONSOR LEAGUE TABLEhealthcare PE returns by firm59
Sponsor League Table — Healthcare PE (≥3 corpus deals)
| Sponsor | Deals | Realized | P25 MOIC | P50 MOIC | P75 MOIC | Distribution | Loss% | 3×+% | Consistency | Avg EV | Sectors |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shore Capital | 3 | 2 | 4.20× | 4.65× | 4.20× | 0.0% | 100.0% | 94 | $172M | women's health | |
| Audax Private Equity | 3 | 1 | 4.50× | 4.50× | 4.50× | 0.0% | 100.0% | 94 | $510M | Ophthalmologyphysician_group | |
| Frazier Healthcare | 7 | 6 | 3.20× | 4.30× | 4.60× | 16.7% | 83.3% | 96 | $274M | Women's Healthbehavioral healthdme_home_health+3 | |
| Waud Capital Partners | 9 | 7 | 3.80× | 4.20× | 8.20× | 0.0% | 100.0% | 100 | $709M | Behavioral HealthPain Managementasc+4 | |
| TA Associates | 4 | 3 | 1.80× | 4.20× | 4.20× | 0.0% | 66.7% | 97 | $320M | digital_healthhealth_ittelehealth | |
| New Mountain Capital | 8 | 4 | 2.00× | 4.15× | 4.50× | 0.0% | 75.0% | 100 | $3.4B | Ambulatory Surgery Clab diagnostics / onvalue_based_care | |
| Veritas | 4 | 2 | 3.50× | 4.15× | 3.50× | 0.0% | 100.0% | 97 | $5.9B | health_it | |
| Nautic Partners | 3 | 2 | 3.60× | 3.70× | 3.60× | 0.0% | 100.0% | 91 | $400M | Behavioral Healthoncology | |
| Optum | 18 | 6 | 3.20× | 3.65× | 3.80× | 0.0% | 100.0% | 96 | $4.5B | ascbehavioral_healthhealth_it+3 | |
| Unitedhealth | 20 | 8 | 3.20× | 3.50× | 3.80× | 0.0% | 100.0% | 95 | $4.3B | ascbehavioral_healthhealth_it+3 | |
| Lhc | 3 | 2 | 3.20× | 3.35× | 3.20× | 0.0% | 100.0% | 88 | $1.8B | home_healthhospice | |
| Ipo | 3 | 2 | 3.10× | 3.30× | 3.10× | 0.0% | 100.0% | 87 | $2.8B | hospitalphysician_group | |
| Warburg Pincus | 25 | 16 | 2.40× | 3.20× | 3.60× | 0.0% | 68.8% | 92 | $779M | Behavioral HealthEmployer Health / OnHealth IT+9 | |
| GTCR | 7 | 1 | 3.20× | 3.20× | 3.20× | 0.0% | 100.0% | 92 | $501M | behavioral_health | |
| Gi | 3 | 2 | 3.20× | 3.20× | 3.20× | 0.0% | 100.0% | 86 | $1.3B | health_it | |
| Revelstoke Capital | 6 | 2 | 2.80× | 3.15× | 2.80× | 0.0% | 50.0% | 92 | $548M | Orthopedicsphysical_therapy | |
| Ares Management | 7 | 2 | 2.60× | 3.05× | 2.60× | 0.0% | 50.0% | 90 | $1.4B | DentalGastroenterologyasc+1 | |
| General Atlantic | 14 | 5 | 2.80× | 3.00× | 3.80× | 0.0% | 40.0% | 90 | $1.5B | Employer Healthdiagnosticsdialysis+3 | |
| Summit Partners | 9 | 5 | 3.00× | 3.00× | 3.10× | 0.0% | 40.0% | 90 | $691M | Healthcare ConsultinSpecialty Pharmacybehavioral_health+4 | |
| Tenet Healthcare | 4 | 2 | 2.20× | 3.00× | 2.20× | 0.0% | 50.0% | 87 | $2.4B | asc | |
| Centeneoration | 4 | 2 | 2.80× | 3.00× | 2.80× | 0.0% | 50.0% | 87 | $9.2B | managed_carepopulation_health | |
| EQT Partners | 3 | 2 | 2.10× | 2.95× | 2.10× | 0.0% | 50.0% | 84 | $2.2B | Revenue Cycle Manage | |
| H.I.G. Capital | 7 | 6 | 2.20× | 2.80× | 2.80× | 0.0% | 16.7% | 88 | $676M | ASCsascphysician_group | |
| Wcas | 4 | 3 | 2.40× | 2.80× | 2.80× | 0.0% | 33.3% | 85 | $1.4B | dialysishome_healthoncology+1 | |
| Leonard Green | 7 | 7 | 0.70× | 2.80× | 3.10× | 42.9% | 42.9% | 77 | $1.1B | Dentaldentalhealth_it+2 | |
| Walgreens Boots Alliance | 4 | 3 | 0.30× | 2.80× | 2.80× | 33.3% | 33.3% | 77 | $3.8B | pharmacy | |
| Acadia Healthcare | 4 | 2 | 2.10× | 2.65× | 2.10× | 0.0% | 50.0% | 84 | $370M | behavioral_health | |
| Omers Private Equity | 3 | 2 | 2.20× | 2.65× | 2.20× | 0.0% | 50.0% | 80 | $400M | DentalSpecialty Pharmacydental | |
| New Enterprise Associates | 5 | 2 | 0.10× | 2.65× | 0.10× | 50.0% | 50.0% | 54 | $1.3B | Radiologymanaged_careradiology | |
| Management | 6 | 5 | 2.50× | 2.60× | 2.80× | 20.0% | 20.0% | 81 | $888M | Medical Devicesbehavioral_healthdme_home_health+1 | |
| KKR | 36 | 21 | 1.80× | 2.60× | 2.80× | 23.8% | 14.3% | 80 | $4.2B | AnesthesiologyGastroenterologyHome & Community Hea+11 | |
| Carlyle Group | 3 | 2 | 2.00× | 2.60× | 2.00× | 0.0% | 50.0% | 79 | $3.1B | cardiologyhealth_it | |
| ABRY Partners | 5 | 4 | 2.40× | 2.55× | 2.60× | 0.0% | 0.0% | 84 | $486M | Dermatologyhome_healthinfusion+1 | |
| Welsh Carson | 24 | 15 | 2.10× | 2.50× | 2.80× | 0.0% | 20.0% | 82 | $1.6B | AnesthesiologyEmployer HealthOccupational Health+12 | |
| Stowe | 16 | 12 | 2.10× | 2.50× | 3.00× | 0.0% | 25.0% | 82 | $1.2B | Employer HealthPost-AcutePrimary Care+8 | |
| Kindred Healthcare | 3 | 1 | 2.50× | 2.50× | 2.50× | 0.0% | 0.0% | 78 | $1.5B | home_health | |
| Owens | 3 | 1 | 2.50× | 2.50× | 2.50× | 0.0% | 0.0% | 71 | $1.9B | Home Health | |
| Humana | 11 | 6 | 2.40× | 2.45× | 2.50× | 0.0% | 16.7% | 82 | $3.4B | home_healthltach_post_acutemanaged_care+2 | |
| Bain Capital | 8 | 3 | 1.50× | 2.40× | 2.40× | 0.0% | 0.0% | 83 | $5.2B | Home Infusionhome_healthmanaged_care_service | |
| Vista Equity Partners | 7 | 4 | 2.30× | 2.40× | 2.50× | 0.0% | 0.0% | 82 | $842M | RCM / health IThealth_it | |
| TPG Capital | 20 | 13 | 2.10× | 2.40× | 2.60× | 7.7% | 15.4% | 81 | $2.6B | Behavioral HealthEmergency MedicinePost-Acute / LTAC+7 | |
| Apollo Global | 5 | 2 | 2.20× | 2.35× | 2.20× | 0.0% | 0.0% | 82 | $3.7B | LTACH / post-acutehospital | |
| Centerbridge Partners | 7 | 5 | 2.00× | 2.20× | 2.80× | 0.0% | 20.0% | 82 | $1.3B | Home Healthbehavioral_healthdialysis+2 | |
| Blackstone | 18 | 11 | 1.20× | 2.20× | 2.50× | 0.0% | 18.2% | 79 | $3.2B | Transplant / Diagnosdme_home_healthhealth_it+3 | |
| Ffl | 4 | 2 | 0.40× | 2.10× | 0.40× | 50.0% | 50.0% | 62 | $620M | Behavioral HealthOphthalmologyphysician_group | |
| Oak Hc | 5 | 3 | 1.20× | 2.00× | 2.00× | 0.0% | 33.3% | 79 | $288M | Digital Healthbehavioral_healthhealth_it | |
| Partners | 6 | 6 | 0.70× | 1.80× | 2.80× | 50.0% | 33.3% | 55 | $964M | dentalhealth_ithospital+1 | |
| Gryphon Investors | 4 | 2 | 1.20× | 1.70× | 1.20× | 0.0% | 0.0% | 68 | $665M | Dentaldental | |
| Amsurg | 3 | 2 | 0.50× | 1.65× | 0.50× | 50.0% | 0.0% | 44 | $6.7B | physician_group | |
| Company | 5 | 2 | 1.50× | 1.55× | 1.50× | 0.0% | 0.0% | 66 | $465M | managed_carephysical_therapy | |
| Kelso | 3 | 2 | 1.50× | 1.55× | 1.50× | 0.0% | 0.0% | 60 | $647M | managed_carephysical_therapy | |
| Deerfield Management | 6 | 4 | 0.10× | 1.20× | 2.00× | 50.0% | 0.0% | 54 | $907M | Value-Based Carebehavioral_healthhealth_it+2 | |
| Rice | 5 | 2 | 0.05× | 1.12× | 0.05× | 50.0% | 0.0% | 39 | $3.0B | Revenue Cycle Managedentalhealth_it | |
| Clayton Dubilier | 4 | 2 | 0.05× | 1.12× | 0.05× | 50.0% | 0.0% | 36 | $2.6B | dentalhealth_it | |
| Public Market (Ipo) | 6 | 6 | 0.45× | 1.05× | 1.40× | 50.0% | 0.0% | 38 | $5.7B | ||
| Advent International | 7 | 4 | 0.30× | 0.35× | 0.40× | 75.0% | 25.0% | 25 | $1.5B | Oncologymanaged_carephysical_therapy | |
| Cvs Health | 5 | 0 | — | — | — | 0.0% | 0.0% | 0 | $5.8B | managed_care | |
| General Catalyst | 9 | 0 | — | — | — | 0.0% | 0.0% | 0 | $937M | behavioral_healthhealth_itmanaged_care+1 | |
| A16Z | 3 | 0 | — | — | — | 0.0% | 0.0% | 0 | $1.2B | managed_careoncology |
Methodology
Consistency Score
Composite 0-100. Rewards: high deal count, low loss rate, tight IQR (low variance),
sector specialization, and median MOIC ≥ 2.0×. Penalizes: high standard deviation,
SPAC/distressed exits, short tenures.
Deal Attribution
Sponsor assigned from buyer field. Multi-sponsor deals (JV, co-invest) count for each
named firm. Name normalization maps ~80 alias forms to canonical names. Deals with
<3 sponsor-attributed outcomes excluded from ranking.
Caveats
Corpus covers announced healthcare PE transactions — survivorship bias exists.
Unrealized deals excluded from MOIC statistics. IRR distorted by partial-period holds.
Large sponsors may show lower P50 because they absorb more difficult sectors.